Cargando…
Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?
SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine...
Autores principales: | Abeygunasekera, Anuruddha, Jayasinghe, Saroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232076/ https://www.ncbi.nlm.nih.gov/pubmed/32492560 http://dx.doi.org/10.1016/j.mehy.2020.109843 |
Ejemplares similares
-
A case of follicular cystitis treated successfully with diethylcarbamazine
por: Sagara Ruwan Kumara, Maduwe Gedara, et al.
Publicado: (2021) -
Prostate cancer in Asia: A collaborative report – The situation in Sri Lanka
por: Abeygunasekera, Anuruddha M.
Publicado: (2015) -
Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2022) -
Diethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins
por: Figueredo-Silva, Jose, et al.
Publicado: (2010) -
Urachal carcinoma
por: Abeygunasekera, Anuruddha M., et al.
Publicado: (2013)